HK1079127A1 - Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases - Google Patents

Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases

Info

Publication number
HK1079127A1
HK1079127A1 HK06101980.4A HK06101980A HK1079127A1 HK 1079127 A1 HK1079127 A1 HK 1079127A1 HK 06101980 A HK06101980 A HK 06101980A HK 1079127 A1 HK1079127 A1 HK 1079127A1
Authority
HK
Hong Kong
Prior art keywords
analysis
urinary tract
methods
urine samples
compositions
Prior art date
Application number
HK06101980.4A
Other languages
English (en)
Inventor
David M Kurnit
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Publication of HK1079127A1 publication Critical patent/HK1079127A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK06101980.4A 2002-03-28 2006-02-16 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases HK1079127A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/108,969 US20030198959A1 (en) 2002-03-28 2002-03-28 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
PCT/US2003/009389 WO2003082202A2 (en) 2002-03-28 2003-03-27 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases

Publications (1)

Publication Number Publication Date
HK1079127A1 true HK1079127A1 (en) 2006-03-31

Family

ID=28673613

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06101980.4A HK1079127A1 (en) 2002-03-28 2006-02-16 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases

Country Status (14)

Country Link
US (1) US20030198959A1 (zh)
EP (1) EP1578357B1 (zh)
JP (2) JP4447328B2 (zh)
CN (1) CN1863923B (zh)
AT (1) ATE458070T1 (zh)
AU (2) AU2003258080A1 (zh)
BR (1) BR0308808A (zh)
CA (1) CA2479379A1 (zh)
DE (1) DE60331353D1 (zh)
HK (1) HK1079127A1 (zh)
IL (1) IL164098A0 (zh)
MX (1) MXPA04009436A (zh)
WO (1) WO2003082202A2 (zh)
ZA (1) ZA200407457B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009517677A (ja) * 2005-11-30 2009-04-30 モザイク・ダイアグノステイツクス・アンド・テラピユーテイツクス・アー・ゲー 腎盂尿管移行部の診断及び評価用のポリペプチドマーカー
WO2008084331A2 (en) * 2006-06-21 2008-07-17 Hopitaux Universitaires De Geneve Biomarkers for renal disorders
US20090068683A1 (en) * 2007-06-11 2009-03-12 Mayo Foundation For Medical Education And Research Markers for preeclampsia
US20090104649A1 (en) 2007-06-11 2009-04-23 Garovic Vesna D Markers for preeclampsia
WO2009059259A2 (en) * 2007-10-31 2009-05-07 Children's Hospital Medical Center Detection of worsening renal disease in subjects with systemic lupus erythematosus
WO2010011460A1 (en) * 2008-07-22 2010-01-28 Siemens Healthcare Diagnostic Inc. Disease specific diagnostic aid
CA2785273A1 (en) 2009-12-21 2011-07-14 Mayo Foundation For Medical Education And Research Early marker of proteinuria in patients treated with an anti-vegf treatment
TW201250248A (en) * 2011-04-25 2012-12-16 Kyowa Medex Co Ltd Prognostication method of renal failure
EP2702998A1 (en) 2012-08-31 2014-03-05 IMBA-Institut für Molekulare Biotechnologie GmbH Therapeutic and diagnostic miRNA regulator in kidney disease
CN105102634A (zh) * 2013-03-15 2015-11-25 伊穆科Gti诊治股份有限公司 使用尿的无细胞dna评价肾状态的方法和组合物
CN104502596A (zh) * 2014-12-23 2015-04-08 温州医科大学 一种慢性肾病诊断试剂盒
CN110506206A (zh) * 2017-03-25 2019-11-26 柏林夏瑞蒂医科大学 作为肾脏疾病的生物标志物的尿液流式细胞术

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379897B1 (en) * 2000-11-09 2002-04-30 Nanogen, Inc. Methods for gene expression monitoring on electronic microarrays
US20020184655A1 (en) * 1997-12-01 2002-12-05 Henryk Lubon Methods for the degradation and detoxification of organic material using urine produced by transgenic animals and related transgenic animals and proteins
EP1055684A4 (en) * 1997-12-05 2002-12-04 Kyogo Itoh TUMORANTIGENS IN THE FORM OF PEPTIDE DERIVATIVES
US6207811B1 (en) * 1998-03-18 2001-03-27 Karl Tryggvason Nephrin gene and protein
FI991369A0 (fi) * 1999-06-15 1999-06-15 Harry Holthoefer Haiman ja munuaiskeräsen ilmentäminen liukoisten proteiinimolekyylien käyttö
KR100771402B1 (ko) * 1999-06-22 2007-10-30 국립감염증연구소장이 대표하는 일본국 Ｓｒｓｖ 검출 킷트
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US20030190624A1 (en) * 2002-03-26 2003-10-09 Chao Zhang Genes expressed with high specificity in kidney

Also Published As

Publication number Publication date
CN1863923A (zh) 2006-11-15
EP1578357A2 (en) 2005-09-28
ZA200407457B (en) 2005-08-31
WO2003082202A2 (en) 2003-10-09
JP2005534892A (ja) 2005-11-17
DE60331353D1 (de) 2010-04-01
CA2479379A1 (en) 2003-10-09
JP4447328B2 (ja) 2010-04-07
EP1578357B1 (en) 2010-02-17
EP1578357A4 (en) 2007-11-28
AU2003258080A1 (en) 2003-10-13
US20030198959A1 (en) 2003-10-23
CN1863923B (zh) 2011-06-29
JP2009207496A (ja) 2009-09-17
ATE458070T1 (de) 2010-03-15
MXPA04009436A (es) 2005-07-05
BR0308808A (pt) 2005-11-22
IL164098A0 (en) 2005-12-18
AU2009200813A8 (en) 2009-04-09
AU2009200813A1 (en) 2009-03-26
WO2003082202A3 (en) 2006-03-23

Similar Documents

Publication Publication Date Title
HK1079127A1 (en) Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
JP5470391B2 (ja) 試料材料の濃縮用の生検器具
MXPA05007063A (es) Aparato para la fabricacion de dispositivos medicos.
WO2008060777A3 (en) Elisa for vegf
NO20050186L (no) Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser
WO2004075733A3 (en) Construction of a deafness gene chip
Braumann et al. Quality of life and need for care in patients with an ostomy: a survey of 2647 patients of the Berlin OStomy-Study (BOSS)
Whitney-Miller et al. Eosinophilic esophagitis: a retrospective review of esophageal biopsy specimens from 1992 to 2004 at an adult academic medical center
WO2005027733A3 (en) Biological markers for diagnosing multiple sclerosis
Chai et al. STROBE: the correlation of Cyr61, CTGF, and VEGF with polymyositis/dermatomyositis
Saeian et al. Unsedated transnasal EGD: an alternative approach to conventional esophagogastroduodenoscopy for documenting Helicobacter pylori eradication
EP1698898A3 (en) Prognostic, diagnostic and therapeutic significance in detecting and using TIN-antigen (Tubulo-Interstitial nephritis antigen) and its segments
Wirth et al. Efavirenz-induced urolithiasis
WO2008045389A3 (en) An improved molecular diagnostic and computerized decision support system incorporating bioinformatic software for selecting the optimum treatment for human cancer
EP1523573B1 (en) Disease detection by digital protein truncation assays
US20070020636A1 (en) Method for early detection and monitoring of diseases by analysis of cell-surface-bound nucleic acids
WO2007058992A3 (en) Mutations and polymorphisms of hdac6
JP2005168474A (ja) ヘリコバクター・ピロリ菌のクラリスロマイシン耐性検査方法
US20220389510A1 (en) Systems and methods for multimodal analysis of surgical drain fluid using interchangeable and customizable nucleic acid based tests
Xiong et al. Risk factors analysis of Flexible Ureteroscopic Lithotripsy with UTI and construction of clinical prediction model
RU2170546C1 (ru) Способ диагностики латентной формы заболеваний урогенитального тракта, передающихся половым путем
WO2005089080A3 (en) Method and kit for screening, pharmaceutical compositions and method for treatment of autoimmune disorders
Polito et al. Evaluation of renal damage by urinary enzyme dosage
Donia et al. Biomass colonization and bioconversion of the molecular characterized Oxalobacter formigenes to mitigate calcium oxlate urolithiasis
CN113242851A (zh) 使用电化学分析确定活性白细胞存在的组合物和方法

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140327